Safety and tolerability of zidovudine
dc.contributor.author | WHO Initiative on HIV/AIDS and Sexually Transmitted Infections | en |
dc.coverage.spatial | Geneva | |
dc.date.accessioned | 2012-06-17T00:42:52Z | |
dc.date.available | 2012-06-17T00:42:52Z | |
dc.date.created | 2000 | en |
dc.date.issued | 2000 | en |
dc.identifier.govdoc | WHO/HSI/2000.01 | en |
dc.identifier.uri | https://iris.who.int/handle/10665/67386 | |
dc.description | WHO/HSI/2000.01 | en |
dc.description | 8 p. | en |
dc.language.iso | en | en |
dc.publisher | World Health Organization | |
dc.publisher | World Health Organization | |
dc.subject.mesh | Zidovudine | en |
dc.subject.mesh | HIV Infections | en |
dc.subject.mesh | Drug Therapy, Combination | en |
dc.subject.mesh | HIV | en |
dc.subject.other | AIDS and its Control | en |
dc.title | Safety and tolerability of zidovudine | en |
dc.subject.meshqualifier | therapeutic use | en |
dc.subject.meshqualifier | drug therapy | en |